NDC 80425-0139-01 - Ketorolac Tromethamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0139
- Requested NDC
- 80425-0139-01
- Package NDCs from labels
- 80425-0139-1, 80425-0139-3, 80425-0139-2, 80425-0139-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ketorolac Tromethamine - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0139-1 | Ketorolac Tromethamine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 5 | |
| 80425-0139-2 | Ketorolac Tromethamine | 9 in 1 BOTTLE | TABLET, FILM COATED | 9 | 5 | |
| 80425-0139-3 | Ketorolac Tromethamine | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0139 | KETOROLAC TROMETHAMINE TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20250101_c1717245-cef3-b3d7-e053-2a95a90a1ac5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0139-1 | EA - Each | 80425-0139 | 70add81b-d8f5-4118-b5c1-05bf84165ade | 1 | 2023-06-06 |
| 80425-0139-2 | EA - Each | 80425-0139 | 0b665173-2504-4c55-b5a5-980fa83937b7 | 1 | 2023-06-06 |
| 80425-0139-3 | EA - Each | 80425-0139 | fcf73ba8-2e41-4714-89c3-f0dc2d794b1e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Leading Pharma, LLC | 04df9620-6dcb-494a-83e2-6d28036be974 | 2024-02-16 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | A-S Medication Solutions | a1ebb51e-4658-4852-bf90-1983a3d44783 | 2023-12-10 | Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Bryant Ranch Prepack | f713500a-20b8-8e20-c4cc-956805170335 | 2023-11-28 | Boxed warning, Warnings, Adverse reactions | ANDA074754 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Bryant Ranch Prepack | 9e5fde54-2206-4072-afb8-4d06a8d314b1 | 2023-11-28 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | e0065781-ea33-4662-a8b1-c936e937ac9f | 2023-11-13 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Asclemed USA, Inc. | 94c7c57a-fd1e-41ab-bc39-9a538f6011d1 | 2023-09-06 | Boxed warning, Warnings, Adverse reactions | ANDA074754 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | 3d88cbe6-5230-47aa-80af-0c41283d1f00 | 2023-08-31 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Medical Purchasing Solutions, LLC | 9e3ddc51-b572-8fe9-e053-2995a90a2f2a | 2023-05-10 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac tromethamine | KETOROLAC TROMETHAMINE | Medical Purchasing Solutions, LLC | ada639d4-babb-2ad0-e053-2a95a90afce7 | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac tromethamine | KETOROLAC TROMETHAMINE | Medical Purchasing Solutions, LLC | e17f583d-8bd4-3ed0-e053-2a95a90a9090 | 2023-04-25 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | b88e562d-226b-4200-afa5-034e628c660f | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | 950b7295-3f68-4027-ac2b-2f7d0f5f8ef9 | 2022-11-18 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | ATNAHS PHARMA US LIMITED | 57ea681c-392e-4f41-a374-91ed20473161 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Proficient Rx LP | 2f27e304-7a96-47b6-8ef1-8a649c25abcf | 2022-11-01 | Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Camber Pharmaceuticals, Inc. | e1fb8753-4695-4cb2-83d7-15d79fbaeeb2 | 2022-10-18 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Asclemed USA, Inc. | 004588ba-e109-4a53-9c9d-a42dea9bb848 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Fresenius Kabi USA, LLC | ccf905ca-e164-4779-9485-2d139c821bad | 2022-09-15 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac tromethamine | KETOROLAC TROMETHAMINE | Asclemed USA, Inc. | ee44c322-4b4b-4397-a1a5-e5b3c3c5a053 | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Proficient Rx LP | c4598ce4-41fb-4cc9-8102-3a66a9bfa36a | 2022-08-01 | Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Proficient Rx LP | f5170993-81a9-4eb7-95ac-60697a5ee1d7 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | ANDA074754 834022 4EVE5946BQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.